Abbott Laboratories (BVMF:ABTT34)

Market Cap	1.15T
Revenue (ttm)	233.66B
Net Income (ttm)	74.22B
Shares Out	n/a
EPS (ttm)	42.43
PE Ratio	15.54
Forward PE	22.10
Dividend	0.74 (1.30%)
Ex-Dividend Date	Jan 14, 2026

Volume	11
Average Volume	399
Open	55.40
Previous Close	55.45
Day's Range	55.20 - 55.40
52-Week Range	49.00 - 67.65
Beta	0.72
RSI	45.13
Earnings Date	Jan 22, 2026

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism,...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1888
• Employees: 114,000
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: ABTT34

Financial Performance

In 2024, Abbott Laboratories's revenue was $41.95 billion, an increase of 4.59% compared to the previous year's $40.11 billion. Earnings were $13.35 billion, an increase of 134.19%.

Financial numbers in USD